Table
2.
HIV status and platelet count grades
HIV
status |
Parameters |
Platelet
count grade |
Totals |
|||||
Unknown |
Severe
decrease |
Moderate
decrease |
Mild
decrease |
Normal |
Increased |
|||
Unknown
|
Patients
(n) |
335 |
55 |
80 |
85 |
373 |
51 |
979 |
Percent
(%) within HIV status |
34.2% |
5.6% |
8.2% |
8.7% |
38.1% |
5.2% |
100.0% |
|
Percentage
(%) within plt count grade |
77.7% |
55.0% |
68.4% |
72.6% |
79.4% |
82.3% |
75.5% |
|
Non-reactive |
Patients
(n) |
37 |
8 |
9 |
10 |
32 |
5 |
101 |
Percent
(%) within HIV status |
36.6% |
7.9% |
8.9% |
9.9% |
31.7% |
5.0% |
100.0% |
|
Percentage
(%) within plt count grade |
8.6% |
8.0% |
7.7% |
8.5% |
6.8% |
8.1% |
7.8% |
|
On
HAART |
Patients
(n) |
1 |
11 |
8 |
4 |
17 |
1 |
42 |
Percent
(%) within HIV status |
2.4% |
26.2% |
19.0% |
9.5% |
40.5% |
2.4% |
100.0% |
|
Percentage
(%) within plt count grade |
0.2% |
11.0% |
6.8% |
3.4% |
3.6% |
1.6% |
3.2% |
|
Reactive,
not on HAART |
Patients
(n) |
58 |
26 |
20 |
18 |
48 |
5 |
175 |
Percent
(%) within HIV status |
33.1% |
14.9% |
11.4% |
10.3% |
27.4% |
2.9% |
100.0% |
|
Percentage
(%) within plt count grade |
13.5% |
26.0% |
17.1% |
15.4% |
10.2% |
8.1% |
13.5% |
|
Totals |
Patients n( % of total patients in study) |
431(33.2) |
100
(7.7) |
117
(9.0) |
117(9.0) |
470(36.2) |
62
(4.8) |
1,297
(100) |
HIV,
Human immunodeficiency virus;
HAART, Highly active anti-retroviral therapy; plt,
platelet.
This table shows that patients on HAART
had the highest percentage (26.2%) of severe thrombocytopenia but it
was also
the group with the least percentage of (2.4%) of unknown platelet
counts.